These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36094435)

  • 1. Role of syndecan-4 in breast cancer pathophysiology.
    Onyeisi JOS; Lopes CC; Götte M
    Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1345-C1354. PubMed ID: 36094435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
    Onyeisi JOS; Greve B; Espinoza-Sánchez NA; Kiesel L; Lopes CC; Götte M
    J Cell Biochem; 2021 Oct; 122(10):1491-1505. PubMed ID: 34180077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
    Lim HC; Multhaupt HA; Couchman JR
    Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-1 (CD138) as a Pathogenesis Factor and Therapeutic Target in Breast Cancer.
    Sheta M; Götte M
    Curr Med Chem; 2021; 28(25):5066-5083. PubMed ID: 34191695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
    Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
    Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
    Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
    J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer.
    Onyeisi JOS; Lopes CC; Götte M
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.
    Subramanian SV; Fitzgerald ML; Bernfield M
    J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.
    Manon-Jensen T; Multhaupt HA; Couchman JR
    FEBS J; 2013 May; 280(10):2320-31. PubMed ID: 23384311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.
    Hassan H; Greve B; Pavao MS; Kiesel L; Ibrahim SA; Götte M
    FEBS J; 2013 May; 280(10):2216-27. PubMed ID: 23289672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate chains of syndecan-1 regulate ectodomain shedding.
    Ramani VC; Pruett PS; Thompson CA; DeLucas LD; Sanderson RD
    J Biol Chem; 2012 Mar; 287(13):9952-9961. PubMed ID: 22298773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
    Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
    FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells.
    Beauvais DM; Rapraeger AC
    Exp Cell Res; 2003 Jun; 286(2):219-32. PubMed ID: 12749851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan Sulfate Proteoglycans in Human Colorectal Cancer.
    Vicente CM; da Silva DA; Sartorio PV; Silva TD; Saad SS; Nader HB; Forones NM; Toma L
    Anal Cell Pathol (Amst); 2018; 2018():8389595. PubMed ID: 30027065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma.
    Lendorf ME; Manon-Jensen T; Kronqvist P; Multhaupt HA; Couchman JR
    J Histochem Cytochem; 2011 Jun; 59(6):615-29. PubMed ID: 21430259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
    Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
    Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 signals independently of beta1 integrins during Raji cell spreading.
    Lebakken CS; McQuade KJ; Rapraeger AC
    Exp Cell Res; 2000 Sep; 259(2):315-25. PubMed ID: 10964499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
    Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
    J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.